About
Okomera develops a platform combining microfluidic tumor-on-chip technology and AI imaging to provide rapid, personalized drug response testing from patient-derived cancer biopsies, supporting cancer treatment and drug development.
Explore Okomera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.